Lynozyfic receives EU approval for relapsed multiple myeloma treatment
New therapy offers hope for patients with limited option Regeneron Pharmaceuticals has announced that the European Commission has conditionally approved...
adminph
Hundreds of genetic links to osteoarthritis unlocked
Study paves the way for personalised therapies for osteoarthritis sufferer Groundbreaking research has identified over 900 genetic links to osteoarthritis,...
Takeda’s Adcetris receives positive opinion for Hodgkin lymphoma treatment
CHMP recommendation brings new hope for patients Takeda has announced a positive opinion from the Committee for Medicinal Products for...
Shaping tomorrow
Today’s leaders are building a stronger, more inclusive future for the industry Research shows that companies with more women in...
Argenx receives positive CHMP opinion for CIDP treatment
VYVGART could be the first CIDP drug with a novel mechanism in 30 years Argenx has announced that the Committee...
Katharina Pink
Aspire Pharma has appointed Katharina Pink as Chief Commercial Officer Aspire Pharma has announced the appointment of Katharina Pink as...
All systems go!
Where to purchase reliable pharmacy automation systems Technological advancements propel the pharmaceutical industry into the future. Better equipment makes it...
Mosaic therapeutics expands pipeline with Astex deal
Mosaic Therapeutics a UK-based oncology company has announced it has in-licensed two clinical-stage oncology programmes from Astex Pharmaceuticals. The agreement...
Acoramidis approved for heart condition treatment
MHRA authorises drug for adults with rare heart muscle damage The Medicines and Healthcare products Regulatory Agency (MHRA) has given...
Genomics study launches to optimise childhood cancer care in Ireland
It is hoped that the MAGIC-I study will support earlier diagnosis and personalised treatment A five-year clinical study aiming to...
Patrick Daly
Terumo BCT has appointed Patrick Daly as Chief Business Officer Terumo Blood and Cell Technologies (Terumo BCT) has announced the...
Empowering antibodies to better activate the immune system
Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these immune...
UCL researchers launch congenital muscular dystrophy research programme
The university has been awarded a £1m grant from LifeArc and Muscular Dystrophy UK Researchers from University College London (UCL)...
Noah Goodman
Kymera Therapeutics has appointed Noah Goodman as Chief Business Officer Clinical-stage biopharma Kymera Therapeutics has announced the appointment Noah Goodman...
BlueRock Therapeutics announces publication in Nature of 18-month data from Phase 1 clinical trial for bemdaneprocel, an investigational cell therapy for Parkinson's disease
BlueRock Therapeutics LP, a clinical-stage cell therapy company and wholly owned subsidiary of Bayer AG, announced the publication of the...
Novavax shares positive real-world results for JN.1-adapted COVID-19 vaccine
The SHIELD-Utah study compared Novavax’s vaccine to the Pfizer/BioNTech mRNA 2024-2025 vaccine Novavax has shared positive preliminary results from a...
Russell Abberley
ABPI has appointed Russell Abberley as President-elect The Association of the British Pharmaceutical Industry (ABPI) has appointed Russell Abberley, Vice...
Existing drug has potential for immune paralysis
When the immune system does not function properly, individuals become more susceptible to infections caused by viruses, bacteria, or fungi....
Study finds pinworm medication has potential to treat aggressive skin cancer
A common pinworm medication may stop and reverse cancer growth in Merkel cell carcinoma, an aggressive form of skin cancer,...
Scientists achieve record-breaking growth in miniature, functional liver models
While organoids aim to mimic human organs, the liver's repertoire of complex functions - and thus the energy it needs...
